When is serum total testosterone measurement indicated in the management of HIV infection in primary care?

1. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013 Mar 27. 27(6):973-9. [Medline].

2. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013. 8(12):e81355. [Medline]. [Full Text].

3. Adapted from Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents, December. Accessed on 9/6/18.

4. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 Jul 24. 320 (4):379-396. [Medline].

5. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013 Jan 17. 368(3):218-30. [Medline]. [Full Text].

6. Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, et al. Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1-Infected Individuals. JAMA Intern Med. 2014 Nov 24. [Medline].

7. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016; vol. 28. Diagnoses of HIV Infection in the United States and Dependent Areas, 2016. Accessed 9/6/18. Available at http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

8. Burgess MJ, Kasten MJ. Human immunodeficiency virus: what primary care clinicians need to know. Mayo Clin Proc. 2013 Dec. 88(12):1468-74. [Medline].

9. [Guideline] Adapted from Guide for HIV/AIDS Clinical Care. U.S. Department of Health and Human Services Health Resources and Services Administration HIV/AIDS Bureau: Published January 2011.

10. [Guideline] Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jan. 58(1):e1-34. [Medline].

11. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion. Lancet. 1985. 1:537-540.

12. Fox R, Eldred LJ, Fuchs EJ, et al. Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men. AIDS. 1987. 1:35-38.

13. Adapted from CDC. MMWR Recommendations and reports December 5. 2008.

14. Freiman JM, Huang W, White L, Geng EH, Hurt CB, Taylor LE, et al. Current Practices of Screening for Incident Hepatitis C Virus Infection among HIV- Infected, HCV-Uninfected Individuals in Primary Care. Clin Infect Dis. 2014 Sep 3. [Medline].

15. Mani D, Aboulafia DM. Screening guidelines for non-AIDS defining cancers in HIV-infected individuals. Curr Opin Oncol. 2013 Sep. 25(5):518-25. [Medline].

16. CDC. Adult immunization schedule. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf. 2016 Feb 04; Accessed: November 7, 2016.

17. MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2016 Nov 4. 65 (43):1189-1194. [Medline]. [Full Text].

18. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1. 63(25 Pt B):2889-934. [Medline].

19. Executive summary: Standards of medical care in diabetes--2013. Diabetes Care. 2013 Jan. 36 Suppl 1:S4-10. [Medline]. [Full Text].

20. Eckhardt BJ, Holzman RS, Kwan CK, Baghdadi J, Aberg JA. Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals. AIDS Patient Care STDS. 2012 Apr. 26(4):197-201. [Medline]. [Full Text].

21. Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients. Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

22. Rathbun RC, Liedtke MD, Lockhart SM, Greenfield RA. Antiretroviral Therapy for HIV Infection. Medscape Reference. September 4, 2012. [Full Text].

23. Centers for Disease Control and Prevention, HIV/AIDS, Basic Statistics. Available at http://www.cdc.gov/hiv/basics/statistics.html. Accessed: 12/23/14.

Jason F Okulicz, MD, FACP, FIDSA Director, HIV Medical Evaluation Unit, Infectious Disease Service, San Antonio Military Medical Center; Associate Professor of Medicine, F Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences; Clinical Associate Professor of Medicine, University of Texas Health Science Center at San Antonio; Adjunct Clinical Instructor, Feik School of Pharmacy, University of the Incarnate Word

Jason F Okulicz, MD, FACP, FIDSA is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, Infectious Diseases Society of America

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Gilead Sciences.

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America; Fellow of the Royal College of Physicians, London

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Medical Association, Association of Professors of Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Deeksha Dewan, MD Fellow in Infectious Diseases, University of Oklahoma Health Sciences Center

Deeksha Dewan, MD is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Nothing to disclose. Michelle R Salvaggio, MD, FACP Assistant Professor, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine; Medical Director of Infectious Diseases Institute, Director, Clinical Trials Unit, Director, Ryan White Programs, Department of Medicine, University of Oklahoma Health Sciences Center; Attending Physician, Infectious Diseases Consultation Service, Infectious Diseases Institute, OU Medical Center

Michelle R Salvaggio, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Merck Honoraria Speaking and teaching